Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 16,440 shares at $67.08 ($1.1M) on 2021-09-01, disclosed to the SEC on 2021-09-02.
Open-market sale of $1.1M ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.08 | 3,822 | $256K | 23.1% |
| 2 | $67.08 | 3,822 | $256K | 23.1% |
| 3 | $67.77 | 4,198 | $284K | 25.6% |
| 4 | $67.77 | 4,198 | $284K | 25.6% |
| 5 | $68.58 | 400 | $27K | 2.5% |
| Total | $67.47 avg | 16,440 |
| $1.1M |
| 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |